CIBA Vision raised its sales by 2 percent in terms of local currencies in the 3rd quarter ended Sept. 30 and by 3 percent for the first nine months of the financial year. Operating income increased by 40 percent in the latest quarter to reach a margin of 14.4 percent on sales of $357 million. For the nine months, the margin was up to 14.3 percent on turnover of $1,050 million. During the same period, currency-neutral sales grew by 5 percent in the USA and by 3 percent in the rest of the world, but in the 3rd quarter sales outside the USA were flat. The parent company, Novartis, raised its total sales of 9 percent in local currencies during the 9-month period and reached an operating margin of 24.2 percent on group turnover of $20.67 billion.